Literature DB >> 26621192

Successful treatment with an anti-PD-1 antibody for progressing brain metastases in renal cell cancer.

C Rothermundt1, C Hader2, S Gillessen3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26621192     DOI: 10.1093/annonc/mdv581

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

Review 1.  Leptomeningeal Metastases.

Authors:  Jerome J Graber; Santosh Kesari
Journal:  Curr Treat Options Oncol       Date:  2018-01-23

Review 2.  Multimodality treatment of brain metastases from renal cell carcinoma in the era of targeted therapy.

Authors:  Bassanelli Maria; Viterbo Antonella; Roberto Michela; Giacinti Silvana; Staddon Anita; Aschelter Anna Maria; D'Antonio Chiara; Marchetti Paolo
Journal:  Ther Adv Med Oncol       Date:  2016-07-25       Impact factor: 8.168

3.  Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors.

Authors:  Deborah T Blumenthal; Michal Yalon; Gilad W Vainer; Alexander Lossos; Shlomit Yust; Lior Tzach; Emanuela Cagnano; Dror Limon; Felix Bokstein
Journal:  J Neurooncol       Date:  2016-07-04       Impact factor: 4.130

Review 4.  History and current state of immunotherapy in glioma and brain metastasis.

Authors:  Tresa McGranahan; Gordon Li; Seema Nagpal
Journal:  Ther Adv Med Oncol       Date:  2017-02-01       Impact factor: 8.168

5.  Partial response of pulmonary adenocarcinoma with symptomatic brain metastasis to nivolumab plus high-dose oral corticosteroid: a case report.

Authors:  Hélène Pluchart; Julian Pinsolle; Julien Cohen; Gilbert R Ferretti; Pierrick Bedouch; Matteo Giaj Levra; Anne-Claire Toffart; Denis Moro-Sibilot
Journal:  J Med Case Rep       Date:  2017-07-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.